Oxidative stress-induced calreticulin expression and translocation: New insights into the destruction of melanocytes

Journal of Investigative Dermatology

Volumn 134, Issue 1, 2014, Pages 183-191

  Zhang, Yajun ^a   Liu, Ling ^a   Jin, Liang ^a   Yi, Xiuli ^a   Dang, Erle ^a   Yang, Yang ^a   Li, Chunying ^a   Gao, Tianwen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; HYDROGEN PEROXIDE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DESTRUCTION; CELL SURFACE; CONTROLLED STUDY; DISEASE DURATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOGENICITY; IN VIVO STUDY; MELANOCYTE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VITILIGO;

EID: 84890966833     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.268     Document Type: Article

References (49)

1. Bickers DR, Athar M (2006) Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 126: 2565-75
2. Bogeski I, Kilch T, Niemeyer BA (2012) ROS and SOCE: recent advances and controversies in the regulation of STIM and Orai. J Physiol 590: 4193-200
3. Briganti S, Picardo M (2003) Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol 17: 663-9
4. Chao MP, Jaiswal S, Weissman-Tsukamoto R et al. (2010) Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2: 63ra94
5. Cho JH, Homma KJ, Kanegasaki S et al. (2001) Activation of human monocyte cell line U937 via cell surface calreticulin. Cell Stress Chaperones 6: 148-52
6. Choi H, Choi H, Han J et al. (2013) IL-4 inhibits the melanogenesis of normal human melanocytes through the JAK2-STAT6 signaling pathway. J Invest Dermatol 133: 528-36
7. Del Cid N, Jeffery E, Rizvi SM et al. (2010) Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway. J Biol Chem 285: 4520-35
8. Donnelly S, Roake W, Brown S et al. (2006) Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum 54: 1543-56
9. Evans CJ, Peto GC, al-Lehyani S et al. (1997) The use of associated particle timing based on the D + D reaction for elemental analysis of bulk samples such as the human body. Appl Radiat Isot 48: 257-66
10. Ezzedine K, Lim HW, Suzuki T et al. (2012) Revised classification/ nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 25:E1-13
11. Fogal V, Zhang L, Krajewski S et al. (2008) Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res 68: 7210-8
12. Frasconi M, Chichiarelli S, Gaucci E et al. (2012) Interaction of ERp57 with calreticulin: analysis of complex formation and effects of vancomycin. Biophys Chem 160: 46-53
13. Fuchs E, Raghavan S (2002) Getting under the skin of epidermal morphogenesis. Nat Rev Genet 3: 199-209
14. Galluzzi L, Kepp O, Kroemer G (2012) Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J 31: 1055-7
15. Gardai SJ, McPhillips KA, Frasch SC et al. (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123: 321-34
16. Garg AD, Krysko DV, Verfaillie T et al. (2012) A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 31: 1062-79
17. Garg AD, Nowis D, Golab J et al. (2010) Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 1805: 53-71
18. Guermonprez P, Saveanu L, Kleijmeer M et al. (2003) ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425: 397-402
19. Hong C, Qiu X, Li Y et al. (2010) Functional analysis of recombinant calreticulin fragment 39-272: implications for immunobiological activities of calreticulin in health and disease. J Immunol 185: 4561-9
20. Ihara Y, Urata Y, Goto S et al. (2006) Role of calreticulin in the sensitivity of myocardiac H9c2 cells to oxidative stress caused by hydrogen peroxide. Am J Physiol Cell Physiol 290:C208-21
21. Jian Z, Li K, Liu L et al. (2011) Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway. J Invest Dermatol 131: 1420-7
22. Jin Y, Birlea SA, Fain PR et al. (2010) Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 362: 1686-97
23. Kawakami T, Hashimoto T (2011) Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol Res Pract 2011: 750342
24. Kobayashi N, Nakagawa A, Muramatsu T et al. (1998) Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 110: 806-10
25. Krause KH, Michalak M (1997) Calreticulin. Cell 88: 439-43
26. Kroll TM, Bommiasamy H, Boissy RE et al. (2005) 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol 124: 798-806
27. Kuraishi T, Manaka J, Kono M et al. (2007) Identification of calreticulin as a marker for phagocytosis of apoptotic cells in Drosophila. Exp Cell Res 313: 500-10
28. Lippens S, Hoste E, Vandenabeele P et al. (2009) Cell death in the skin. Apoptosis 14: 549-69
29. Liu B, Jian Z, Li Q et al. (2012) Baicalein protects human melanocytes from H(2)O(2)-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway. Free Radic Biol Med 53: 183-93
30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-8
31. Michalak M, Groenendyk J, Szabo E et al. (2009) Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 417: 651-66
32. Mosca PJ, Robertson GP (2011) Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression. Cancer Biol Ther 11: 581-3
33. Mosenson JA, Zloza A, Nieland JD et al. (2013) Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med 5: 174ra28
34. Obeid M, Panaretakis T, Joza N et al. (2007a) Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ 14: 1848-50
35. Obeid M, Tesniere A, Ghiringhelli F et al. (2007b) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13: 54-61
36. Obeid M, Tesniere A, Panaretakis T et al. (2007c) Ecto-calreticulin in immunogenic chemotherapy. Immunol Rev 220: 22-34
37. Perez CA, Fu A, Onishko H et al. (2009) Radiation induces an antitumour immune response to mouse melanoma. Int J Radiat Biol 85: 1126-36
38. Porcellini S, Traggiai E, Schenk U et al. (2006) Regulation of peripheral T cell activation by calreticulin. J Exp Med 203: 461-71
39. Prathyuman S, Sellappa S, Joseph S et al. (2010) Enhanced calreticulin expression triggers apoptosis in the MCF-7 cell line. Asian Pac J Cancer Prev 11: 1133-6
40. Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Experimental Dermatology 17: 1063-72
41. Rezaei N, Gavalas NG, Weetman AP et al. (2007) Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol 21: 865-76
42. Rutkevich LA, Williams DB (2011) Participation of lectin chaperones and thiol oxidoreductases in protein folding within the endoplasmic reticulum. Curr Opin Cell Biol 23: 157-66
43. Spisek R, Charalambous A, Mazumder A et al. (2007) Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 109: 4839-45
44. Spritz RA (2008) The genetics of generalized vitiligo. Curr Dir Autoimmun 10: 244-57
45. Tarr JM, Young PJ, Morse R et al. (2010) A mechanism of release of calreticulin from cells during apoptosis. J Mol Biol 401: 799-812
46. van den Boorn JG, Konijnenberg D, Dellemijn TA et al. (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 129: 2220-32
47. Wang HT, Lee HI, Guo JH et al. (2012) Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules. Int J Cancer 130: 2892-902
48. Wu J, Zhou M, Wan Y et al. (2013) CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Rep 7: 237-41
49. Yang F, Sarangarajan R, Le Poole IC et al. (2000) The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol 114: 157-64